TY - JOUR
T1 - Effect of indolealkylamine manipulations on locomotor activity in rats
AU - Jacobs, B. L.
AU - Eubanks, E. E.
AU - Wise, W. D.
PY - 1974/7
Y1 - 1974/7
N2 - The effect of various manipulations of the indolealkylamine system upon locomotor activity in adult male rats was investigated. 6-fluorotryptophan, a rapidly acting tryptophan hydroxylase inhibitor, produced a small, but significant decrease in activity. Neither variations in the dietary content of l-tryptophan, nor systemic injections of l-tryptophan had any effect on activity. However, pretreatment with the monoamine oxidase inhibitor, pargyline, caused l-tryptophan injections to produce a syndrome characterized by large increases in activity, tremor, rigidity, hyper-reactivity, streotyped head movements, and a general sympathetic response. Pretreatment with spiroperidol, a presumed specific dopamine receptor blocker, abolished all signs of the syndrome except for the rigidity and hyper-reactivity. By contrast, the noradrenergic receptor blockers, phenoxybenzamine and propanolol, had no observable effect on the syndrome.
AB - The effect of various manipulations of the indolealkylamine system upon locomotor activity in adult male rats was investigated. 6-fluorotryptophan, a rapidly acting tryptophan hydroxylase inhibitor, produced a small, but significant decrease in activity. Neither variations in the dietary content of l-tryptophan, nor systemic injections of l-tryptophan had any effect on activity. However, pretreatment with the monoamine oxidase inhibitor, pargyline, caused l-tryptophan injections to produce a syndrome characterized by large increases in activity, tremor, rigidity, hyper-reactivity, streotyped head movements, and a general sympathetic response. Pretreatment with spiroperidol, a presumed specific dopamine receptor blocker, abolished all signs of the syndrome except for the rigidity and hyper-reactivity. By contrast, the noradrenergic receptor blockers, phenoxybenzamine and propanolol, had no observable effect on the syndrome.
UR - http://www.scopus.com/inward/record.url?scp=0016138665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016138665&partnerID=8YFLogxK
U2 - 10.1016/0028-3908(74)90045-8
DO - 10.1016/0028-3908(74)90045-8
M3 - Article
C2 - 4280024
AN - SCOPUS:0016138665
SN - 0028-3908
VL - 13
SP - 575
EP - 583
JO - Neuropharmacology
JF - Neuropharmacology
IS - 7
ER -